[go: up one dir, main page]

GB0517184D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0517184D0
GB0517184D0 GBGB0517184.8A GB0517184A GB0517184D0 GB 0517184 D0 GB0517184 D0 GB 0517184D0 GB 0517184 A GB0517184 A GB 0517184A GB 0517184 D0 GB0517184 D0 GB 0517184D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0517184.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0517184.8A priority Critical patent/GB0517184D0/en
Publication of GB0517184D0 publication Critical patent/GB0517184D0/en
Priority to PCT/EP2006/008204 priority patent/WO2007022937A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0517184.8A 2005-08-22 2005-08-22 Compounds Ceased GB0517184D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0517184.8A GB0517184D0 (en) 2005-08-22 2005-08-22 Compounds
PCT/EP2006/008204 WO2007022937A1 (en) 2005-08-22 2006-08-18 Pyridazine derivatives with antiinflammatory activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0517184.8A GB0517184D0 (en) 2005-08-22 2005-08-22 Compounds

Publications (1)

Publication Number Publication Date
GB0517184D0 true GB0517184D0 (en) 2005-09-28

Family

ID=35098093

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0517184.8A Ceased GB0517184D0 (en) 2005-08-22 2005-08-22 Compounds

Country Status (2)

Country Link
GB (1) GB0517184D0 (en)
WO (1) WO2007022937A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5603770B2 (en) 2007-05-31 2014-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング CCR2 receptor antagonist and use thereof
WO2009140078A1 (en) * 2008-05-16 2009-11-19 The Procter & Gamble Company Treatment of lower urinary tract dysfunction with cb2-receptor-selective agonists
US20120053164A1 (en) 2008-12-19 2012-03-01 Boehringer Ingelheim International Gmbh Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
WO2010123822A1 (en) * 2009-04-20 2010-10-28 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
EP2513093B1 (en) 2009-12-17 2014-08-27 Boehringer Ingelheim International GmbH New ccr2 receptor antagonists and uses thereof
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2571870B1 (en) 2010-05-17 2015-01-21 Boehringer Ingelheim International GmbH Ccr2 antagonists and uses thereof
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
EP2576538B1 (en) 2010-06-01 2015-10-28 Boehringer Ingelheim International GmbH New CCR2 antagonists
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
US9273011B2 (en) * 2011-10-28 2016-03-01 Inhibitaxin Limited Substituted pyridazines for the treatment of pain
KR20210130843A (en) 2013-07-31 2021-11-01 노파르티스 아게 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions
WO2017004537A1 (en) 2015-07-02 2017-01-05 Centrexion Therapeutics Corporation (4-((3r,4r)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2r,6s)-6-(p-tolyl)tetrahydro-2h-pyran-2-yl)methylamino)pyrimidin-4yl)methanone citrate
AR117169A1 (en) 2018-11-28 2021-07-14 Bayer Ag (TIO) PYRIDAZINE AMIDES AS FUNGICIDE COMPOUNDS
AR117461A1 (en) 2018-12-20 2021-08-04 Bayer Ag HETEROCYCLYL PYRIDAZINE COMPOUNDS AS FUNGICIDES
MX420421B (en) 2019-07-22 2025-02-10 Boehringer Ingelheim Int N-(6-METHOXY)PYRIZADIN-3-YL)AMINE, N-METHYL DERIVATIVES AS AUTOTAXIN (ATX) MODULATORS FOR THE TREATMENT OF INFLAMMATORY OR FIBROTIC AIRWAY DISEASES
EP4156936A1 (en) 2020-05-27 2023-04-05 Bayer Aktiengesellschaft Active compound combinations
EP4167740A1 (en) 2020-06-18 2023-04-26 Bayer Aktiengesellschaft Active compound combinations
CN118580191A (en) * 2022-01-28 2024-09-03 和记黄埔医药(上海)有限公司 Intermediates for the preparation of imidazo[1,2-b]pyridazine compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162859A0 (en) * 2002-02-05 2005-11-20 Novo Nordisk As Novel aryl-and heteroarylpiperazines
KR20060054392A (en) * 2003-07-29 2006-05-22 노보 노르디스크 에이/에스 Their use as pyridazinyl-piperazine and histamine H3 receptor ligands
FR2864080B1 (en) * 2003-12-23 2006-02-03 Sanofi Synthelabo 1-PIPERAZINE-AND-1-HOMOPIPERAZINE-CARBOXYLATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Also Published As

Publication number Publication date
WO2007022937A1 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
GB0508472D0 (en) Compounds
GB0503962D0 (en) Compounds
GB0507602D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0517184D0 (en) Compounds
GB0502316D0 (en) Compounds
GB0508463D0 (en) Compounds
GB0502310D0 (en) Compounds
GB0502299D0 (en) Compounds
GB0505084D0 (en) Compounds
GB0503961D0 (en) Compounds
AP2007004220A0 (en) Motilide compounds
GB0505086D0 (en) Compounds
GB0506467D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0508460D0 (en) Compounds
GB0505735D0 (en) Compounds
GB0503145D0 (en) Compounds
GB0501985D0 (en) Compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0501861D0 (en) Compounds
GB0500891D0 (en) Compounds
GB0502544D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)